NEJM This Week — June 2, 2022
Featuring articles on an albuterol–budesonide rescue inhaler in asthma, the efficacy of a plant-based SARS-CoV-2 vaccine, the efficacy and safety of a spike protein subunit vaccine, and neoantigen T-cell receptor gene therapy in pancreatic cancer; a review article on the uses of a GFR and albuminuria level in kidney disease; a Clinical Problem-Solving describing the after-dinner dip; and Perspective articles on navigating the loss of abortion services, on HIV prevention and the 340B Drug Pricing Program, and on the care and treatment of Black girls in America.
